✦ LIBER ✦

Minocycline is protective in a mouse model of Huntington's disease

✍ Scribed by Steven Hersch; Klaus Fink; Jean Paul Vonsattel; Robert M. Friedlander

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 69 KB
Volume: 54
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.21891

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minocycline is not beneficial in a pheno

Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease

✍ Elsa Diguet; Richard Rouland; François Tison 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Additive neuroprotective effects of mino

Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS

✍ Wenhua Zhang; Malini Narayanan; Robert M. Friedlander 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Enhanced sensitivity to N-methyl-D-aspar

Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease

✍ Michael S. Levine; Gloria J. Klapstein; Ahrin Koppel; Ehud Gruen; Carlos Cepeda; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

We used two mouse models of Huntington's disease (HD) to examine changes in glutamate receptor sensitivity and striatal electrophysiology. One model, a transgenic, consisted of mice expressing exon 1 of the human HD gene and carrying 141-157 CAG repeat sequences (R6/2 line). The second model, a CAG

Neuroprotective effects of (±)-kavain in

Neuroprotective effects of (±)-kavain in the MPTP mouse model of Parkinson's disease

✍ Nicole Schmidt; Boris Ferger 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

This is the first study to investigate the potential protective effects of the lipophilic kavapyrone (+/-)-kavain in the experimental MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD). Male C57BL/6 mice were treated with (+/-)-kavain (50, 100, or 200 mg/kg i.p.) o

A Genetic Study of red cell osmotic frag

A Genetic Study of red cell osmotic fragility in Huntington's disease

✍ McCormack, Michael K. ;Lazzarini, Alice ;Toke, David ;Lepore, Frederick 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 1 views

## Abstract The erythrocyte osmotic fragility was evaluated on 19 unmedicated subjects with Huntington's disease and 42 individuals at 50% risk, 27 children at 25% risk, and a group of 60 hematologically normal control persons. Five older subjects at 50% risk for Huntington's disease as well as 6 A

Huntington's disease—growth of fibroblas

Huntington's disease—growth of fibroblast cultures in lipid-deficient medium: A preliminary report

✍ Dr. John H. Menkes; Amalia Hanoch 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 1 views

## Abstract When skin fibroblast cultures derived from subjects with Huntington's disease (HD) were grown in medium supplemented with lipid‐deficient serum (LDS), growth rates were less than those of control cultures. The mean percentage increase in generation time for nine control cultures incurre